{
  "docId": "019de073-5c75-763a-a0f1-d995dc5da488",
  "docSlug": "01bee26c2c6ee992ec5e01a8e02dc689",
  "documentTitle": "Myovant Sciences | Results Presentation Deck | 34 slides",
  "authorId": "myovant-sciences",
  "authorName": "Myovant Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 34,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "appendix_disclosure",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 22,
  "notes": "Clinical safety data table for MYFEMBREE.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-5c75-763a-a0f1-d995dc5da488/20",
  "deckHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488",
  "deckJsonHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488.json",
  "deckAnchorHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.03,
        "y": 0.8
      },
      "kind": "paragraph",
      "text": "Adverse reactions most commonly reported in the SPIRIT extension study were similar to those in the placebo-controlled SPIRIT 1 and 2 studies.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "207bc615-eaf8-4c69-97dd-b9d889141628",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "NOTE: Table includes data from SPIRITY 1 and 2 studies pooled only. Does not include extension study. (1) Includes hot flush, hyperhidrosis, night sweats, and flushing. (2) Includes affect lability, affective disorder, anxiety, depressed mood, depression, emotional distress, generalized anxiety disorder, irritability, mixed anxiety and depressive disorder, mood altered, mood swings, and suicidal ideation. (3) Includes menorrhagia, metrorrhagia, vaginal hemorrhage, uterine hemorrhage, polymenorrhea, and menstruation irregular. (4) Includes libido decreased, libido disorder, and female sexual arousal disorder. Full prescribing information for MYFEMBREE, including Black Box Warning, is available at www.myovant.com/myfembree-prescribing-information.pdf NOT FOR PROMOTION.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00c873cc-c580-4117-b5f9-cc336a45c31d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.94,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "table",
      "text": "Table comparing MYFEMBREE (N=418) and Placebo (N=416) across 11 adverse reaction categories.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2de0bc1d-b4ba-485e-a57c-48b07000e406",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Adverse Reactions (≥ 3% of Women) Treated with MYFEMBREE and at a Greater Incidence Than Placebo",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2783efd3-a245-4316-973e-f86616c7a707",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "8b1c5e8a-f2ef-4be9-b4e5-0ae8478ae0d9",
      "evidence": "The slide features a table comparing adverse reactions between MYFEMBREE and Placebo.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}